Scientists identify metabolic weakness in aggressive brain cancer, point to diet-based treatment

Glioblastoma is a fast-growing, aggressive brain cancer with poor prognosis, affecting patients and families who urgently need more effective treatment options.

For decades, glioblastoma has resisted medicine's best efforts, leaving patients and families with few options against one of the most aggressive cancers known. Now, an international team of researchers has found something quietly remarkable: the tumor carries a metabolic weakness, one that existing steroid treatments inadvertently expose, and that a carefully restricted diet may be able to exploit. The discovery, emerging from laboratories across five European countries, does not yet offer a cure — but it offers something medicine has long sought in this disease: a foothold.

Scientists identify metabolic weakness in aggressive brain cancer, point to diet-based treatment

Cobertura Relacionada

Receba o Register no seu e-mail